The neurochemical pathology of Alzheimer's disease, the most common cause of dementia, has received increasingly more attention in the last decade. Work from neurotransmitter systems are pathologically involved in this neurodegenerative disorder. Neurons affected include cholinergic neurons in the basal forebrain, and two groups of neuropeptide-containing cells: somatostatin neurons in the cerebral cortex and other brain areas, and CRF-containing cells in the cerebral cortex and striatum. Other peptidergic neurons such as those containing cholecystokinin, vasopressin and vasoactive-intestinal peptide apparently spared. In the present competitive renewal application we seek to scrutinize in detail, the dynamic state of the cholinergic neurons using tissue obtained in the Rapid Autopsy Procedure (20-60 min after death). By measuring markers of neuronal integrity, neuronal activity (high affinity choline uptake), receptor number and affinity, and receptor occupancy (Rb+ flux), the dynamic state of cholinergic neurotransmission will be assessed in several brain regions from histologically- confirmed Alzheimer's disease and age- and sex-matched controls. Such experiments will probably provide the mechanism(s) by which choline and lecithin therapy are ineffective in Alzheimer's disease. In addition, we shall continue our work on peptidergic (SRIF, CRF, and others) systems in Alzheimer's disease including a detailed mapping of the pathological involvement of CRF- and SRIF containing neurons in the Alzheimer's disease by measurement of the concentrations of those peptides in more than 30 brain areas. Moreover, SRIF and CRF receptor binding will be assessed, as will functional responses of these receptors, i.e. cyclic AMP production and phosphoinositide hydrolysis. The majority of these studies are feasible because of the unique availability of the rapid autopsy tissue - our research group is the only in the world conducting this procedure. These studies will provide novel data that should result in the development of a rational drug therapy in patients with Alzheimer's disease. Finally the measurement of several neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease, patients with other neuropsychiatric disorders and controls may provide a diagnostic test for this disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH040524-04
Application #
3378817
Study Section
Psychopathology and Clinical Biology Research Review Committee (PCB)
Project Start
1985-07-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Nemeroff, C B (1998) Psychopharmacology of affective disorders in the 21st century. Biol Psychiatry 44:517-25
Owens, M J; Morgan, W N; Plott, S J et al. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-22
Behan, D P; Khongsaly, O; Owens, M J et al. (1997) Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain. J Neurochem 68:2053-60
Nemeroff, C B; DeVane, C L; Pollock, B G (1996) Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153:311-20
Krishnan, K R; Tupler, L A; Ritchie Jr, J C et al. (1996) Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry 40:69-71
Bissette, G; Seidler, F J; Nemeroff, C B et al. (1996) High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann N Y Acad Sci 777:197-204
Slotkin, T A; Nemeroff, C B; Bissette, G et al. (1994) Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest 94:696-702
Auchus, A P; Green, R C; Nemeroff, C B (1994) Cortical and subcortical neuropeptides in Alzheimer's disease. Neurobiol Aging 15:589-95
Molchan, S E; Hill, J L; Martinez, R A et al. (1993) CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18:509-19
Fossey, M D; Lydiard, R B; Ballenger, J C et al. (1993) Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders. J Neuropsychiatry Clin Neurosci 5:335-7

Showing the most recent 10 out of 43 publications